Cutaneous anaplastic large-cell lymphoma with dramatic response to brentuximab vedotin; [Brentuximab vedotine dramatik yanıtlı kutanöz anaplastik büyük hücreli lenfoma]
dc.contributor.author | Şahin M. | |
dc.contributor.author | Miskioğlu M. | |
dc.contributor.author | Inanır I. | |
dc.contributor.author | Akar H. | |
dc.contributor.author | Neşe N. | |
dc.contributor.author | Temiz P. | |
dc.contributor.author | Aydoğdu İ. | |
dc.date.accessioned | 2025-04-10T11:06:02Z | |
dc.date.available | 2025-04-10T11:06:02Z | |
dc.date.issued | 2021 | |
dc.description.abstract | [No abstract available] | |
dc.identifier.DOI-ID | 10.4274/tjh.galenos.2020.2020.0512 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14701/46444 | |
dc.publisher | Turkish Society of Hematology | |
dc.title | Cutaneous anaplastic large-cell lymphoma with dramatic response to brentuximab vedotin; [Brentuximab vedotine dramatik yanıtlı kutanöz anaplastik büyük hücreli lenfoma] | |
dc.type | Letter |